Drugmaker, Investors Reach $20M Settlement In Stock Drop Suit

Mealey's (September 7, 2017, 8:34 AM EDT) -- SEATTLE — Pharmaceutical company CTI BioPharma Corp. will pay $20 million to settle claims that it, its CEO and members of its board of directors and underwriters of two of the...
To view the full article, register now.